CHE vs DVA
As of Sep 20, 2026, Chemed (CHE) scores 6.3/10 and Davita (DVA) 7.0/10 on AlphaStocks' five-model composite, so DVA scores higher. CHE trades 9% below its model fair value; DVA trades 29% below its model fair value.
CHE
CHEMED CORP
6.3
Consider Buy
$503.05
DVA
DAVITA INC.
7.0
Consider Buy
$183.88
CHE vs DVA: Which is the Better Investment?
CHEMED CORP (CHE) scores 6.3/10 while DAVITA INC. (DVA) scores 7.0/10 on AlphaStocks' composite model. DAVITA INC. has the higher composite rating of Consider Buy. On a P/E basis, DAVITA INC. trades at 12.9x, making it the more attractively priced of the two. DAVITA INC. trades further below its estimated fair value.
This comparison is algorithmically generated and is not financial advice.
| Metric | CHE | DVA |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.3/10 | 7.0/10▲ |
| Rating | Consider Buy | Consider Buy▲ |
| Price | $503.05 | $183.88 |
| P/E Ratio | 21.4 | 12.9▲ |
| ROE | -9.6%▲ | -176.4% |
| Market Cap | $7B | $13B |
| Fair Value | $550.66 | $260.62 |
| Dividend Yield | — | — |
| Sector Rank | #39 of 168 | #14 of 168▲ |
| Model Verdicts | ||
| Piotroski | Attractive | Attractive |
| Buffett | Neutral | Attractive▲ |
| Graham | Neutral | Neutral |
| Lynch | Caution | Neutral▲ |
| Greenblatt | Limited Data | Attractive▲ |
Related comparisons
CHE vs DVA: Which Stock Scores Higher?
CHEMED CORP (CHE) and DAVITA INC. (DVA) are both in the Health Care sector. DVA currently leads with a composite score of 7.0/10 (Consider Buy) compared to CHE's 6.3/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer